Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Classical hematology 1

Conditions

Colorectal Neoplasms 1Anemia, Iron-Deficiency 1

Interventions

ferric carboxymaltose 4iron isomaltoside 1000 3ferric derisomaltose 2Iron-Dextran Complex 2ferroglycine sulfate 1Tomography, X-Ray Computed 1Surveys and Questionnaires 1Sodium Chloride 1Saline Solution 1Radiotherapy, Intensity-Modulated 1Niferex 1Gastroscopy 1Ferric Oxide, Saccharated 1Control Groups 1Colonoscopy 1Colonography, Computed Tomographic 1Betaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Anemia, Iron-Deficiency × ferroglycine sulfate × Clear all
NCT02469480 2020-10-19

Intravenous Ferric Carboxymaltose vs. Oral Iron Substitution in Patients With Metastatic Colorectal Cancer (CRC) and Iron Deficiency Anemia: a Randomized Multicenter Treatment Optimization Study.

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Phase 2 Completed
64 enrolled
Classical hematologyGastrointestinal

Colorectal Neoplasms, Anemia, Iron-Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡